Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06350253 · ClinicalTrials.gov registry record
Comparison Of Measured To Predicted Resting Metabolism
A clinical trial, sponsored by Ohio University.
- Completed
- Registry status
- 90
- Enrollment target
NCT06350253: Completed study, sponsored by Ohio University.
NCT06350253 is a clinical trial that has completed, run by Ohio University. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06350253 has completed, sponsored by Ohio University.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to compare RMR values from the BIA, predicted equations, and indirect calorimetry.
Interventions
- DIAGNOSTIC_TEST Metabolic cart
- DIAGNOSTIC_TEST MedGem
- DIAGNOSTIC_TEST BIA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2023-03-14 |
| Est. Completion | 2024-12-31 |
What the finished NCT06350253 record still lists
NCT06350253 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Metabolic cart is the first listed.
NCT06350253 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06350253 about?
NCT06350253 is a clinical study titled "Comparison Of Measured To Predicted Resting Metabolism". The purpose of this study is to compare RMR values from the BIA, predicted equations, and indirect calorimetry.
What is the current status of trial NCT06350253?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2023-03-14. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT06350253?
The interventions under investigation include: Metabolic cart (DIAGNOSTIC_TEST), MedGem (DIAGNOSTIC_TEST), BIA (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06350253?
This trial is sponsored by Ohio University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI